You are here

AstraZeneca

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono

Fierce Pharma

Tue, 03/1/22 - 10:32 am

Ono Pharmaceutical

AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006

Biopharma Reporter

Tue, 03/1/22 - 10:23 am

monoclonal antibodies

transthyretin amyloid cardiomyopathy

AstraZeneca doubles down on animation—with a '60s spin this time—in new Breztri ad campaign

Fierce Pharma

Mon, 02/28/22 - 09:17 am

It looks like the final round of Emergent's AstraZeneca Covid-19 doses have been released

Endpoints

Tue, 02/22/22 - 11:12 pm

Emergent BioSolutions

AstraZeneca CEO snared more than $18M last year as his company worked through highs and lows of vaccine launch

Fierce Pharma

Tue, 02/22/22 - 10:56 am

Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial

Pharmaforum

Mon, 02/21/22 - 10:35 am

clinical trials

HER2-low breast cancer

Roche and AstraZeneca settle years long patent battle over Ultomiris — report

Endpoints

Sun, 02/20/22 - 11:48 am

ASCO-GU – prostate cancer PARPS move to the front line

EP Vantage

Sun, 02/20/22 - 11:44 am

prostate cancer

PARP inhibitors

Clovis Oncology

AstraZeneca scores another industry victory over the federal government in 340B litigation

Endpoints

Thu, 02/17/22 - 11:23 pm

Covid infects biopharma’s biggest sellers

EP Vantage

Thu, 02/17/22 - 10:45 am

AstraZeneca/Merck come out of ASCO GU with a big win over J&J in battle over prostate cancer franchises

Endpoints

Tue, 02/15/22 - 11:31 pm

prostate cancer

AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M

Fierce Pharma

Mon, 02/14/22 - 10:53 am

AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world

Fierce Biotech

Thu, 02/10/22 - 10:46 am

Pascal Soriot: AstraZeneca 'on track' to hit big $40B goal, capping years-long turnaround campaign

Endpoints

Thu, 02/10/22 - 10:42 am

Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?

Motley Fool

Tue, 02/8/22 - 09:56 am

intranasal vaccines

AstraZeneca Will Ax Its U.S. Workers’ Pension Plan This Year

Bloomberg

Mon, 02/7/22 - 11:28 pm

employee benefits

Watch out, AstraZeneca: UCB uncorks late-stage success for $2.1B Soliris rival

Endpoints

Fri, 02/4/22 - 11:11 am

clinical trials

myasthenia gravis

AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests

Fierce Pharma

Mon, 01/31/22 - 10:43 am

ASCO-GI – immuno-oncology makes progress in liver cancer

EP Vantage

Fri, 01/21/22 - 10:37 am

COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ

Fierce Pharma

Thu, 01/20/22 - 11:23 pm

Moderna Therapeutics

Pages